Le Lézard
Classified in: Health
Subject: SVY

The global ophthalmology devices market at a CAGR of almost 4% during the forecast period


NEW YORK, July 23, 2019 /PRNewswire/ --

Global Ophthalmology Devices Market: About this market

Ophthalmology devices discussed in this report include both diagnostic and surgical equipment to treat glaucoma, refraction, cataract, retinal disorders, dry eye, myopia, hypermetropia, and others. This ophthalmology devices market analysis considers sales from the vision care, ophthalmology surgical devices, and ophthalmology diagnostic devices segments to hospitals and clinics, ASCs and physicians' offices, and optical retailers. Our analysis also considers the sales of Ophthalmology devices in Asia, Europe, North America, and ROW. In 2018, the vision care segment held the highest market share. This trend is expected to remain prevalent over the forecast period. Factors such as the rising prevalence of refractive disorders and technological advances in eyewear are helping the vision care segment in maintaining its leading market position. Also, our global ophthalmology devices report has observed market growth factors such as the increasing prevalence of ophthalmic diseases, technological advances in ophthalmology devices, and the rising number of initiatives to increase awareness and customer training. However, high cost and limited reimbursement, limitations, and complications associated with ophthalmology devices, and shortage of skilled ophthalmologists may hamper the growth of the ophthalmology devices industry over the forecast period.

Read the full report: https://www.reportlinker.com/p03348524/?utm_source=PRN

Global Ophthalmology Devices Market: Overview

Technological advances in ophthalmology devices

Vendors have been leveraging on the rising need for effective treatment options from ophthalmologists and are releasing cataract, glaucoma, and vitreoretinal surgical devices with advanced technologies. These advanced ophthalmology devices are improving surgical outcomes, reducing perioperative morbidity, effectively addressing various eye conditions, and facilitating fast recovery without side-effects. As a result, the demand for technologically advanced ophthalmology devices is growing, which will lead to the expansion of the global ophthalmology devices market at a CAGR of almost 4% during the forecast period.

Increasing medical tourism for low-cost ophthalmology

India, Mexico, South Korea, and Thailand provide low-cost, high-quality medical assistance, including ophthalmic procedures. India is the leading country for medical tourism. It has accredited specialty eye care hospitals, which have advanced infrastructure and well-trained surgeons, have been performing glaucoma procedures, cataract surgeries, corneal laser surgeries, and others at low cost. As a result, an increasing number of patients from the US and Canada, wherein medical services are expensive, are traveling to the above-mentioned countries to avail medical services. Therefore, this trend will have a positive impact on the overall market growth.

Competitive Landscape

With the presence of several major players, the global ophthalmology devices market is moderately fragmented. This robust vendor analysis is designed to help clients in improving their market position, and in line with this, this report provides a detailed analysis of several leading ophthalmology devices manufacturers, which include Alcon Inc., Bausch Health Companies Inc., Carl Zeiss AG, EssilorLuxottica SA, HOYA Corp., Johnson & Johnson Services Inc., NIDEK Co. Ltd., and The Cooper Co. Inc.

Also, the ophthalmology devices market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

Read the full report: https://www.reportlinker.com/p03348524/?utm_source=PRN

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker


These press releases may also interest you

at 09:15
Kane Biotech Inc. ("Kane") announces that it will be hosting a webinar on Thursday April 18th, 2024 at 4:15pm Eastern Time. Marc Edwards, Kane's President & CEO, will share his thoughts on what the sale of STEM Animal Health, which should...

at 09:15
NMDP BioTherapies?, formerly Be The Match BioTherapies, a leader in cell and gene therapy development support, unveiled substantial upgrades to its cellular starting material offerings, including incorporating a Drug Master File (DMF) with its...

at 09:12
On April 20, 2024, the Lennox-Gastaut Syndrome (LGS) Foundation will mobilize families, friends, and communities around the world to 'Step Towards the Cures, Together' at their 9th Annual Walk 'n' Wheel for LGS Research. Click here to learn how you...

at 09:10
TetraScience, the Scientific Data and AI Cloud company, today announced a strategic partnership with Google Cloud at the Bio-IT World Conference & Expo to speed up drug development and other scientific discoveries. By bringing the Tetra Scientific...

at 09:07
MOBILion Systems, Inc., pioneers in separation science, is excited to announce its expansion into Europe with additions to its sales, service, and support organization. This strategic move aims to better serve the scientific community within the...

at 09:05
QuantHealth, an AI-powered clinical trial design company, today announced the formation of its inaugural Advisory Board. Founding members Michel Vounatsos, former CEO of Biogen, Rob Scott, former Chief Medical Officer for AbbVie, and Christian Hein,...



News published on and distributed by: